Welcome to our dedicated page for Horizon Space Acquisition II news (Ticker: HSPT), a resource for investors and traders seeking the latest updates and insights on Horizon Space Acquisition II stock.
Horizon Space Acquisition II Corp. (HSPT) is a Nasdaq-listed blank check company, or special purpose acquisition company (SPAC), incorporated in the Cayman Islands and classified in the Financial Services sector under Shell Companies. News related to HSPT focuses on its efforts to identify, finance, and complete an initial business combination, as well as the regulatory and financing steps it takes along that path.
A key development highlighted in recent announcements is HSPT’s definitive Business Combination Agreement with SL Bio Ltd., a clinical-stage biomedical company focused on cellular and gene therapies for cancer treatment and regenerative medicine. Coverage of this agreement includes details of the proposed transaction structure, the creation of SL Science Holding Limited (PubCo) as a Cayman Islands exempted company, and the expectation that PubCo’s ordinary shares will be listed on Nasdaq if the proposed transactions are completed.
News about Horizon Space Acquisition II Corp. also includes updates on its capital structure and financing arrangements, such as unsecured promissory notes issued to its sponsor or sponsor designees. These notes may be used for working capital or to fund extension fees that allow the company to extend the deadline to complete its initial business combination, and they may be convertible into private units consisting of ordinary shares, rights, and, in some cases, warrants.
Investors and observers following HSPT’s news can expect coverage of SEC filings, including current reports on Form 8-K that describe material definitive agreements, extensions of the business combination deadline, and other significant corporate events. Monitoring this news flow provides insight into the progress of the proposed business combination with SL Bio Ltd. and the ongoing steps Horizon Space Acquisition II Corp. takes within its SPAC framework.
Horizon Space Acquisition II Corp (NASDAQ: HSPT) postponed its Extraordinary General Meeting from 9:00 a.m. ET on February 3, 2026 to 9:00 a.m. ET on February 12, 2026 to allow additional shareholder engagement. There is no change to location, record date (Dec 29, 2025) or meeting proposals.
The physical meeting remains at Robinson & Cole LLP, 666 Third Avenue, 20th Floor, New York, NY, and will be available via teleconference. The public shareholder redemption request deadline is extended to 5:00 p.m. ET on February 10, 2026. Contact information for transfer agent and proxy solicitor was provided for shareholder questions.
Horizon Space Acquisition II Corp. (NASDAQ: HSPT) has announced that starting February 5, 2025, holders of the 5,750,000 units sold in its initial public offering can begin separately trading the ordinary shares and rights included in the Units. The Units, which include those sold during the full exercise of the underwriters' over-allotment option, will continue trading on NASDAQ under 'HSPTU,' while separated ordinary shares and rights will trade under 'HSPT' and 'HSPTR' respectively.
Unit holders must contact their brokers and the company's transfer agent, VStock Transfer , to separate their units. The initial public offering was underwritten by Maxim Group , following an SEC-approved registration statement (File No. 333-282758) effective November 12, 2024. The offering was conducted solely through a prospectus available through Maxim Group or the SEC's EDGAR system.
FAQ
What is the current stock price of Horizon Space Acquisition II (HSPT)?
What is the market cap of Horizon Space Acquisition II (HSPT)?
